US Patent 8614178 Pharmaceutical composition for treatment of dry eye syndrome

Patent 8614178 was granted and assigned to Novaliq on December, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

‌

Novaliq

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8614178

Date of Patent

December 24, 2013

Patent Application Number

13513886

Date Filed

December 13, 2010

Patent Citations Received

‌

US Patent 12059449 Ophthalmic composition for treatment of dry eye disease

‌

US Patent 12128010 Semifluorinated compounds and their compositions

‌

US Patent 11951098 Therapeutic agent for meibomian dysfunction

‌

US Patent 11987623 Stabilized antibody compositions

‌

US Patent 12005033 Compositions comprising mixtures of semifluorinated alkanes

Patent Primary Examiner

‌

Marcela Cordero Garcia

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8614178 Pharmaceutical composition for treatment of dry eye syndrome

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API